# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001558370-16-004199
Filing Date
2016-03-17
Accepted
2016-03-17 07:16:30
Documents
3
Period of Report
2016-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | vygr-20160317x8k.htm | 8-K | 38101
2 | EX-99.1 | vygr-20160317ex991b6bed3.htm | EX-99.1 | 97263
3 | GRAPHIC | vygr20160317ex991b6bed3001.jpg | GRAPHIC | 1250070
| Complete submission text file | 0001558370-16-004199.txt |  | 1854073

Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 161511238
SIC: 2836 Biological Products, (No Diagnostic Substances)